OasisLMS

Included with ACAAM membership. Join ACAAM to access this and other educational offerings.

ACAAM Members, select "Get Started" to register for this session.

This session provides a focused, case-based review of cannabis use disorder and related conditions across clinical settings, including epidemiology, pharmacology, and the endocannabinoid system. Aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas, the session explores the assessment, diagnosis, and management of cannabis-related disorders, as well as evolving considerations related to emerging cannabis products and unregulated cannabinoids.

What This Covers

• Epidemiology, patterns of use, and risk factors for cannabis use and cannabis-related disorders
• Pharmacology of cannabis and core concepts related to the endocannabinoid system
• Recognition and management of cannabis intoxication and withdrawal
• Associated clinical syndromes, including anxiety, psychosis, and sleep disturbances
• Screening strategies and diagnostic criteria for cannabis use disorder
• Current treatment approaches, including psychotherapy and emerging pharmacologic options
• Considerations related to evolving cannabis products, unregulated cannabinoids, and clinical decision-making across care settings

How This Resource Is Used

This session is designed for on-demand learning, focused content review, and board preparation. It may be used to reinforce foundational addiction medicine concepts, supplement fellowship training, or support preparation for addiction medicine certification examinations. Learners can engage with specific topic areas independently or complete the full session as part of a structured study plan.

Greg S. Swartzentruber, MD Dr. Swartzentruber is an addiction medicine physician at UPMC (Harrisburg), where he serves as Addiction Medicine Fellowship Director. He is board certified in Addiction Medicine, Medical Toxicology, and Emergency Medicine and practices at the UPMC Center for Addiction Medicine. He completed his medical degree at Penn State College of Medicine, followed by residency training in emergency medicine and fellowship training at UPMC, and is actively involved in the clinical management of patients with substance use disorders.

Ian Klansek, MD At the time of presentation, Dr. Klansek is an addiction medicine fellow at UPMC (Harrisburg). Dr. Klansek completed an emergency medicine residency at Penn State Health Milton S. Hershey Medical Center.

To support a meaningful learning experience and recognize your participation:

• After viewing a minimum of 50% of the session, the evaluation will become available
• We encourage you to complete the evaluation to reflect on the content and provide valuable feedback
• Upon completion, a Certificate of Participation will be issued for your records